Deals
To acquaint you better with the varying transactions that we have advised our clients on over the past 33 years, we have attached "tombstone" listings of our representative transactions.
Recent Updates
- January 7, 2026
Art Technology Acquisition Corp.
EGS represented Clear Street LLC in Art Technology Acquisition Corp.'s initial public offering in the amount of
$220,000,000 - January 7, 2026
Compass Digital Acquisition Corp.
EGS represented Compass Digital Acquisition Corp. in the signing of its definitive agreement and plan of merger for a business combination with Key Mining Corp. with an equity value for Key Mining Corp. of
$230,000,000 - December 23, 2025
LM Funding America, Inc.
EGS represented Maxim Group LLC in LM Funding America, Inc.'s registered direct offering in the amount of
$6,500,000 - December 19, 2025
Nouveau Monde Graphite Inc.
EGS represented Maxim Group LLC in Nouveau Monde Graphite Inc.'s public offering in the amount of
$20,000,000 - December 17, 2025
Akari Therapeutics, Plc
EGS represented Ladenburg Thalmann & Co. Inc. in Akari Therapeutics, Plc's registered direct offering in the amount of
$5,000,000 - November 11, 2025
WISeKey International Holding AG
EGS represented WISeKey International Holding AG in the signing of its business combination agreement with Columbus Acquisition Corp. in the amount of
$250,000,000 - October 29, 2025
Genprex, Inc.
EGS represented H.C. Wainwright & Co. in Genprex, Inc.'s registered direct offering in the amount of
$10,000,000 - October 28, 2025
Annovis Bio, Inc.
EGS represented H.C. Wainwright & Co. in Annovis Bio, Inc.'s registered direct offering in the amount of
$3,400,000 - October 27, 2025
Robin Energy Ltd.
EGS represented Maxim Group LLC in Robin Energy Ltd.'s registered direct offering in the amount of
$7,000,000 - October 24, 2025
Genprex, Inc.
EGS acted as counsel to H.C. Wainwright & Co. in Genprex, Inc.'s registered direct offering in the amount of up to
$8,100,000 - October 22, 2025
Largo Inc.
EGS represented H.C. Wainwright & Co. in Largo Inc.'s registered direct and private placement offering in the amount of
$23,400,000 - October 21, 2025
Citius Pharmaceuticals, Inc.
EGS represented H.C. Wainwright & Co. in Citius Pharmaceuticals, Inc.'s registered direct offering in the amount of
$6,000,000
Browse the Deal Archive
Law Firm Rankings Our growth and successes led our Firm to achieve improved rankings among all U.S. law firms.
#1
in PIPEs/Registered Directs (agent's counsel)
#2
in the U.S. for most actively involved in IPOs of all law firms from 2017 to 2021
#1
SPAC Law Firm in the U.S. for SPAC IPOs and SPAC Acquisitions
$5 billion
raised through 25 SPAC IPOs in 2024